Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has provided an announcement.
Recce Pharmaceuticals Ltd has announced the application for quotation of 811,062 fully paid ordinary shares on the ASX. These shares were issued as part of compensation for services provided to the company, including legal, corporate advisory, investor relations, and stakeholder engagement support. This move is expected to enhance the company’s financial flexibility and strengthen its operational capabilities, potentially impacting its market position positively.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of new classes of synthetic anti-infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens.
Average Trading Volume: 163,480
Technical Sentiment Signal: Sell
Current Market Cap: A$92.28M
See more data about RCE stock on TipRanks’ Stock Analysis page.